SE9803155D0 - A new composition - Google Patents

A new composition

Info

Publication number
SE9803155D0
SE9803155D0 SE9803155A SE9803155A SE9803155D0 SE 9803155 D0 SE9803155 D0 SE 9803155D0 SE 9803155 A SE9803155 A SE 9803155A SE 9803155 A SE9803155 A SE 9803155A SE 9803155 D0 SE9803155 D0 SE 9803155D0
Authority
SE
Sweden
Prior art keywords
composition
component
disorders
new composition
dicyclobutylamino
Prior art date
Application number
SE9803155A
Other languages
Swedish (sv)
Inventor
John Evenden
Seth-Olov Thorberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9803155A priority Critical patent/SE9803155D0/en
Publication of SE9803155D0 publication Critical patent/SE9803155D0/en
Priority to CA002342223A priority patent/CA2342223A1/en
Priority to JP2000569801A priority patent/JP2002524507A/en
Priority to PCT/SE1999/001596 priority patent/WO2000015217A1/en
Priority to EP99951318A priority patent/EP1113792A1/en
Priority to AU63779/99A priority patent/AU6377999A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Abstract

The invention relates to a composition comprising a first component (a) which is (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate monohydrate and a second component (b) which is a 5-HT reuptake inhibitor excluding citalopram and paroxetine, the preparation thereof, pharmaceutical formulations containing said composition, use of and a method of treatment of affective disorders such as mood disorders and anxiety disorders with said composition as well as a kit containing said composition.
SE9803155A 1998-09-16 1998-09-16 A new composition SE9803155D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9803155A SE9803155D0 (en) 1998-09-16 1998-09-16 A new composition
CA002342223A CA2342223A1 (en) 1998-09-16 1999-09-13 A new composition
JP2000569801A JP2002524507A (en) 1998-09-16 1999-09-13 New composition
PCT/SE1999/001596 WO2000015217A1 (en) 1998-09-16 1999-09-13 A new composition
EP99951318A EP1113792A1 (en) 1998-09-16 1999-09-13 A new composition
AU63779/99A AU6377999A (en) 1998-09-16 1999-09-13 A new composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803155A SE9803155D0 (en) 1998-09-16 1998-09-16 A new composition

Publications (1)

Publication Number Publication Date
SE9803155D0 true SE9803155D0 (en) 1998-09-16

Family

ID=20412626

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803155A SE9803155D0 (en) 1998-09-16 1998-09-16 A new composition

Country Status (6)

Country Link
EP (1) EP1113792A1 (en)
JP (1) JP2002524507A (en)
AU (1) AU6377999A (en)
CA (1) CA2342223A1 (en)
SE (1) SE9803155D0 (en)
WO (1) WO2000015217A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60122015T2 (en) 2000-10-13 2006-11-23 Neurosearch A/S TREATMENT OF AFFECTIVE DISORDERS BY COMBINED EFFECT OF A NICOTINE RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE
US8309107B2 (en) 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9501567D0 (en) * 1995-04-27 1995-04-27 Astra Ab A new combination

Also Published As

Publication number Publication date
JP2002524507A (en) 2002-08-06
AU6377999A (en) 2000-04-03
CA2342223A1 (en) 2000-03-23
EP1113792A1 (en) 2001-07-11
WO2000015217A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
SE9501567D0 (en) A new combination
PT1237553E (en) COMBINATION OF AN INHIBITOR OF RECAPTACAO OF SEROTONIN AND AN ANTAGONISTA, OF AN INVESTMENT AGONIST OR OF A PARTIAL AGONIST FOR 5-HT2C
HUP9701068A2 (en) Pharmaceutical compositions comprising mirtazapine and one or more selective serotonin reuptake inhibitors
NO20060402L (en) 3-amino choman and 2-aminotetraline derivatives
DE60044152D1 (en) Bupropion metabolite for the treatment of anxiety
DE602004015257D1 (en) USE OF THE (1S, 2R) -MILNACIPRANE ENANTIOMER FOR THE MANUFACTURE OF A MEDICAMENT
SE9800836D0 (en) New Compounds
EA199900669A1 (en) INTERMEDIATE COMPOUNDS FOR OBTAINING N-[AMINOIMINOMETHYL OR AMINOMETHYL-PHENYL] SUBSTITUTED PROPYLAMIDES
DE60200492D1 (en) Combination of an inhibitor of serotonin reuptake and an atypical antipsychotic for the treatment of depression, obsessive compulsive disorder and psychosis
BR0109211A (en) 5-ht1a Activity Compounds Useful for Treatment of External Retinal Disorders
DK1436257T3 (en) Oxime analogs of 1-alpha, 25-dihydroxy-vitamin-D3 with low calcium effect
EA200001218A1 (en) COMBINATION THERAPY FOR THE TREATMENT OF RESISTANT DEPRESSION
NO20061575L (en) Process for the preparation of renzapride and its intermediates
AR015448A1 (en) COMBINATION OF A 5-HT REABSORTION INHIBITOR WITH AN H5-HT1B ANTIGONIST OR PARTIAL AGONIST, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATION CONTAINING IT, ITS USE TO PREPARE MEDICINES TO TREAT KITTEN
DE602004031893D1 (en) Use of the enantiomer (1S, 2R) of milnacipran for the manufacture of a medicament
EA200300519A1 (en) CONNECTIONS OF DERIVATIVES OF BENZOTHIOPHENE, THE METHOD OF THEIR RECEPTION AND APPLICATION
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
AR054435A1 (en) AGENT FOR PROFILAXIS OR THERAPY AGAINST DEPRESSION OR DISORDER OF ANXIETY
SE9804126D0 (en) New pharmaceutical composition
HUP0303270A2 (en) Isoxazoline derivatives as anti-depressants, process for their preparation and pharmaceutical compositions containing them
CR7271A (en) NEW MELATONIN-BASED PHARMACEUTICAL FORMULATIONS AND SIMILAR COMPOUNDS FOR USE IN SOUND DISORDERS
SE9803155D0 (en) A new composition
BRPI0411175A (en) combination of analgesic modafinil and an antidepressant for the treatment of depression
BRPI0411174A (en) combination of analgesic modafinil and an antidepressant for the treatment of depression
SE9803157D0 (en) A new composition